Lev Pharmaceuticals, Inc. to Present at the Needham & Co. 7th Annual Biotechnology and Medical Technology Conference
Published: Jun 05, 2008
NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Needham & Co. Biotechnology and Medical Technology Conference, being held June 11-12 at The New York Palace Hotel, New York, NY. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ [C1 inhibitor (human)]. The Lev presentation is scheduled to begin at 10:30 a.m. Eastern Standard Time on Wednesday, June 11th.